Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Centessa Pharmaceuticals (CNTA) Accumulated Depreciation & Amortization (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $921000.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization fell 2.23% to $921000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $921000.0 through Dec 2025, down 2.23% year-over-year, with the annual reading at $921000.0 for FY2025, 2.23% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $921000.0 at Centessa Pharmaceuticals, up from $680000.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $942000.0 in Q4 2024, with the low at $28000.0 in Q1 2022.
  • Average Accumulated Depreciation & Amortization over 4 years is $420875.0, with a median of $384500.0 recorded in 2023.
  • The sharpest move saw Accumulated Depreciation & Amortization surged 518.32% in 2023, then dropped 9.58% in 2025.
  • Over 4 years, Accumulated Depreciation & Amortization stood at $131000.0 in 2022, then soared by 518.32% to $810000.0 in 2023, then rose by 16.3% to $942000.0 in 2024, then fell by 2.23% to $921000.0 in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $921000.0, $680000.0, and $443000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.